Hong Kong Paper and Forestry Products Stock News

SEHK:1093
SEHK:1093Pharmaceuticals

CSPC Pharmaceutical Group Q1 Margin Compression Reinforces Bearish Profitability Narratives

CSPC Pharmaceutical Group (SEHK:1093) has kicked off 2026 with Q1 revenue of C¥6.5b and basic EPS of C¥0.075, setting the tone for how its earnings story may evolve from here. Over recent quarters the company has seen quarterly revenue move between C¥6.1b and C¥7.0b, while basic EPS has ranged from about C¥0.033 to C¥0.129, giving investors a clear view of how the topline and per share earnings have tracked together. With trailing net profit margins easing over the last year, this latest...
SEHK:622
SEHK:622Consumer Finance

Undiscovered Gems In Asia For May 2026

As global markets navigate through inflation concerns and geopolitical tensions, small-cap stocks in Asia present intriguing opportunities for investors seeking growth potential. With the recent outperformance of small-cap and value stocks over their larger counterparts, identifying companies with strong fundamentals and unique market positions can be key to uncovering undiscovered gems in this dynamic region.
SEHK:1810
SEHK:1810Tech

Xiaomi (SEHK:1810) Valuation After Q1 2026 Earnings Slump And EV And AI Investment Push

Xiaomi (SEHK:1810) is back in focus after reporting a sharp year-on-year drop in first quarter 2026 revenue and net income, alongside higher memory costs and pressure on its core smartphone business. See our latest analysis for Xiaomi. The HK$28.56 share price reflects a weak recent patch, with the stock down 29.1% year to date on a share price basis and the 1 year total shareholder return falling 44.8%. However, the 3 year total shareholder return is still very strong. If Xiaomi's mix of...